99548441
Dec 15, 2025
Pharmaceutical preparations for the treatment of gastroparesis; Pharmaceutical preparations for the treatment and prevention of motion sickness; Pharmaceutical preparations for the treatment and prevention of nausea; Pharmaceutical preparations for the treatment and prevention of vomiting; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by an over-expression of the neuropeptide known as substance P; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by overstimulation of the neurokinin-1 (NK-1) receptor; Pharmaceutical preparations for the treatment of nausea in gastroparesis; Pharmaceutical preparations for the treatment of symptoms of gastroparesis; Pharmaceutical preparations for the treatment and prevention of vomiting induced by motion; Pharmaceutical preparations for the treatment of vomiting in gastroparesis; Pharmaceutical preparations for the treatment and prevention of nausea induced by motion
Pharmaceuticals